Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Marimed Inc (OP: MRMD )

0.2300 -0.0100 (-4.17%)
Streaming Delayed Price Updated: 3:56 PM EDT, May 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 537,931
Open 0.2400
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2400
Today's Range 0.2072 - 0.2400
52wk Range 0.2031 - 0.5450
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cannabis Stock Gainers And Losers From May 28, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
DEA Rules THCA Is Not Legal Hemp Amid Industry Shake-Up And Farm Bill Debate On Delta-8 THC Prohibition
DEA rules THCA not legal hemp, sparking industry concerns. Congress debates Farm Bill changes. Curaleaf criticizes amendment. Read now! 
Via Benzinga

Performance

YTD
-16.97%
-16.97%
1 Month
-11.03%
-11.03%
3 Month
-20.14%
-20.14%
6 Month
-24.12%
-24.12%
1 Year
-43.21%
-43.21%

More News

Read More
Bearish Sentiment Across The Cannabis Space - Check Full Movers For May 27, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
MRMD Stock Earnings: MariMed Beats Revenue for Q1 2024
Via InvestorPlace
Cannabis Stock Movers For May 24, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
House Committee Approval Of Amendment Eliminating 90% Of Hemp-Dervied Products Could Drive Wedge Between Cannabis And Hemp Industries
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Rescheduling Signals Strong Returns, Tax Breaks Could Increase This Stock's Market Cap By 170%
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From May 14, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Analysts May Need To Revise Cannabis Stock Projections For 2024: 10 Companies Surpass EBITDA Estimates By $37M
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Chart Of The Week: Analysts React Meekly To Strong Q1'24 Earnings
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For May 9, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Monday For Marijuana Stocks - Target Group, Item 9 Labs Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For May 1, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Tuesday For Marijuana Stocks - Elixinol Wellness, Item 9 Labs Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Industry Leaders React To DEA's Historic Move To Reschedule Cannabis
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For April 25, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For April 22, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Investors Share 'Chips Make Chunks' Wisdom For Business Expansion At Benzinga Conference
Via Benzinga
Topics Cannabis
Exposures Cannabis
4/20 Cannabis Retail Frenzy: Leading Brands Ready For Record Sales Surge - Who Will Lead?
Via Benzinga
Topics Cannabis
Exposures Cannabis
'A F—ed-Up Situation,' Says MariMed CCO About How State Regulations Complicate Cannabis Edibles Strategy
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Brands Leading Market Expansion In East & Midwest: A Look At Prices And Trends
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From April 16, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For April 11, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
MariMed Is On A Roll: Partners With Two Iconic Music Venues In Boston, Acquires Another Illinois Cannabis Dispensary
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For April 10, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.